If pregnant/lactating or taking any medications, please consult your physician prior to use
Addressing dementia risk likely requires simultaneous support of metabolism, mitochondria, vascular health, and cellular health with GLP-1s providing a powerful foundation upon which multi-modal brain health strategies can be built
Starting semaglutide before thyroid function is optimized may mask underlying symptoms or create confusion about which medication is responsible for symptom changes
Desire for gradual weight loss Patients choose microdosing because it provides sustained and gradual weight loss, as standard dosing of GLP-1 receptor agonists may cause rapid weight loss that is more visible on the face (Ozempic face)
Investing in prevention and disease management is far more responsible than paying for emergency interventions, dialysis, amputations, heart attacks, and disability, especially in the era of HR1